290 related articles for article (PubMed ID: 7545433)
21. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
22. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
[TBL] [Abstract][Full Text] [Related]
23. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
[TBL] [Abstract][Full Text] [Related]
25. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.
Besmer P; Manova K; Duttlinger R; Huang EJ; Packer A; Gyssler C; Bachvarova RF
Dev Suppl; 1993; ():125-37. PubMed ID: 7519481
[TBL] [Abstract][Full Text] [Related]
26. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
27. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.
Hibi K; Takahashi T; Sekido Y; Ueda R; Hida T; Ariyoshi Y; Takagi H; Takahashi T
Oncogene; 1991 Dec; 6(12):2291-6. PubMed ID: 1722571
[TBL] [Abstract][Full Text] [Related]
28. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
[TBL] [Abstract][Full Text] [Related]
29. Localization of stem cell factor (SCF) and c-kit mRNA in human placental tissue and biological effects of SCF on DNA synthesis in primary cultured cytotrophoblasts.
Saito S; Enomoto M; Sakakura S; Ishii Y; Sudo T; Ichijo M
Biochem Biophys Res Commun; 1994 Dec; 205(3):1762-9. PubMed ID: 7529021
[TBL] [Abstract][Full Text] [Related]
30. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
31. c-KIT expression enhances the leukemogenic potential of 32D cells.
Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
[TBL] [Abstract][Full Text] [Related]
32. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
33. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
34. Steel and c-kit in the development of avian melanocytes: a study of normally pigmented birds and of the hyperpigmented mutant silky fowl.
Lecoin L; Lahav R; Martin FH; Teillet MA; Le Douarin NM
Dev Dyn; 1995 May; 203(1):106-18. PubMed ID: 7544170
[TBL] [Abstract][Full Text] [Related]
35. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG
Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175
[TBL] [Abstract][Full Text] [Related]
36. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia.
Pietsch T
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):285-6. PubMed ID: 7687773
[TBL] [Abstract][Full Text] [Related]
37. The expression of cytokine receptors by purified hemopoietic stem cells.
Visser JW; Rozemuller H; de Jong MO; Belyavsky A
Stem Cells; 1993 Jul; 11 Suppl 2():49-55. PubMed ID: 7691328
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
